Skip to content

Clinical trials

Phase 3 Ischemic Stroke trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 3 Clear all

257 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20045
20054
20065
20071
20083
20093
20102
20111
201212
20136
20147
20155
20164
20175
201814
20197
20208
202110
202223
202320
202433
202541
202635

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed86
Recruiting71
Not yet recruiting35
Unknown status31
Terminated23
Active, not recruiting6
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Tiantan Hospital26
Kafrelsheikh University18
Capital Medical University9
Second Affiliated Hospital, Zhejiang University, School of Medicine9
Assistance Publique - Hôpitaux de Paris6
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University6
General Hospital of Shenyang Military Region4
Peking Union Medical College Hospital4
Neuroscience Trials Australia3
Samsung Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke257
Stroke82
Brain Ischemia8
Cerebrovascular Disorders8
Ischemic Attack, Transient8
Cerebral Infarction7
Atrial Fibrillation5
Carotid Stenosis5
Recurrence5
Atherosclerosis4

Trials

Showing 1 to 25 of 257. Each trial links to its page on Pharma Observatory.

157 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.